ViCentra announced today that it appointed Tom Arnold as its new CEO to accelerate growth for the Kaleido automated insulin delivery system. Arnold joins the Dutch insulin pump maker with nearly 25 years of leadership experience in medtech and diabetes. His track record includes spearheading commercialization initiatives, business strategy and product launches for medical device […]
Personnel Moves
Embecta to lay off 118 in Massachusetts following patch pump program discontinuation
Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees. The state received Embecta’s Worker Adjustment and Retraining Notification (WARN) submission on Nov. 26 — the same day it announced plans to discontinue its insulin patch pump program and restructure. The discontinuation of the patch pump program came not […]
Insulin pump maker PharmaSens adds former ADA leaders, medtech veterans to board
PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors. Gabbay joins the board of the Swiss company after spending time in leadership roles with the American Diabetes Association (ADA). Peterson spent more than two decades as a medtech CEO and more recently served as executive […]
Know Labs appoints new chief science, technology officers
Know Labs (NYSE:KNW) announced today that it appointed a new chief science officer (CSO) and interim chief technology officer (CTO). The company picked Dominic Klyve to serve as CSO, while John Cronin takes up the interim CTO role. Seattle-based Know Labs develops non-invasive diagnostic technology, including a wearable continuous glucose monitor (CGM). The company unveiled […]
Glooko announces CEO transition with $100M financing
Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO. Russ Johannesson said on LinkedIn that he stepped down from the CEO post at Glooko. He held the corner office for six-and-a-half years as Alvarez now takes over. Alvarez brings more than two decades of […]
ApiJect Systems promotes COO from within
Injection delivery system developer ApiJect announced that it promoted Molly Weaver to the position of chief operating officer. Weaver’s background includes both the pharmaceutical and medical technology markets. Her experience spans strategy, product development and execution across a broad range of industrialization and drug delivery systems. Most recently, Weaver served as chief technology officer at ApiJect. […]
Fresenius Kabi USA appoints new president
Fresenius Kabi announced that Arunesh Verma joined as the president of Fresenius Kabi USA and as a member of its global executive leadership team. As a member of the executive leadership team, Verma reports to CEO Pierluigi Antonelli. He holds responsibility for the commercial operations of Fresenius Kabi in the U.S., succeeding John Ducker. Ducker […]
Tandem Diabetes Care has a new COO
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed Jean-Claude “JC” Kyrillos as its new EVP and COO. Kyrillos’ appointment goes into effect on June 21, 2024. He joins Tandem with more than 20 years of experience in global executive leadership across medtech, digital health and healthcare management. Most recently, Kyrillos served in operating company […]
Medtronic Diabetes has a new medical affairs director
Medtronic (NYSE:MDT) announced today that Dr. Goran Petrovski joined its Diabetes operating unit as medical affairs director. His role includes shaping the clinical evidence strategy and product design for Medtronic’s diabetes technology. The company also expects him to strengthen its presence in Central Europe, the Middle East and Africa. Petrovski brings more than 20 years […]
Stevanato Group brings former CEO back to corner office
Stevanato Group (NYSE:STVN) announced today that its board of directors appointed Franco Stevanato as its new CEO. Stevanato, currently a board director and the company’s executive chair, succeeds Franco Moro in the corner office. Moro’s employment agreement continues through June 30, 2024, after which he will remain on the company’s board. This marks Stevanato’s second […]
